Fact CheckerSign in

NCT06672770Not yet recruiting

Effect of Functional Inspiratory Muscle Training in Patients with Multiple Sclerosis

Investigation of the Effects of Functional Inspiratory Muscle Training on Respiratory Muscle Strength, Functional Exercise Capacity and Cognitive Function in Patients with Multiple Sclerosis

Source: ClinicalTrials.gov · Last updated 4 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study aims to investigate the effects of functional inspiratory muscle training, basic inspiratory muscle training and physical activity in addition to respiratory exercises on respiratory muscle strength, respiratory function, cognition, walking, balance, functional exercise capacity, physical activity, quality of life and core muscles in volunteer Multiple Sclerosis (MS) patients. This study is planned as a prospective, randomized and experimental study.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
63 (estimated)
First submitted
30 Oct 2024
Start date
1 Nov 2024
Primary completion date
31 Oct 2025
Lead sponsor
Selcuk University
NCT number
NCT06672770

What you commit to

  • Study type: Interventional
  • Planned participants: 63
  • From 1 Nov 2024 to the primary completion date, 31 Oct 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Those with neurological diseases other than MS,
  • Those with chronic cardiac or pulmonary diseases such as chronic obstructive pulmonary disease (COPD), asthma, interstitial lung disease and heart failure that may affect respiratory muscle strength and respiratory functions,
  • Individuals who have had pneumonia due to viral or bacterial infection in the last six months or COVID-19 positive individuals proven by PCR-RT,
  • Those with diagnosed psychiatric disorders,

Other

  • Those who have functional exercise restrictions,
  • Those with orthopedic problems, persistent neck and back pain and/or radiculopathy that prevent them from participating in the study,
  • Those who use tobacco and tobacco products,
  • Participants with cooperation problems that may prevent evaluations and treatment will not be included in the study.

Who the study is looking for

  • Diagnosed with Relapsing Remitting Type Multiple Sclerosis (RRMS),
  • EDSS (Expanded Disability Status Scale in MS: EDSS) score ranging from 1-5,
  • Able to communicate (speak, understand, read and understand Turkish),
  • Individuals who have not had an attack in the last three months,
  • Individuals who have not received respiratory-based rehabilitation in the last six months will be included in the study.

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Selcuk University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation
Coordinator of this site? Confirm its status
KonyaTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.